GeneTx

GeneTx Biotherapeutics is a biotechnology company dedicated to developing effective therapies for the treatment of Angelman syndrome. The company offers an antisense therapy that silences gene expression by binding to RNA produced by the gene, thus enabling access to cutting-edge treatments for Angelman syndrome.